Anti-PAX8 antibody [EPR18715]
- Recombinant
- Advanced Validation
- RabMAb
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(17 Publications)
Anti-PAX8 antibody [EPR18715] (ab191870) is a rabbit monoclonal antibody detecting PAX8 in Western Blot, IHC-P, IHC-Fr, ICC/IF. Suitable for Human, Mouse.
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
Paired box protein Pax-8, PAX8
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PAX8 antibody [EPR18715] (AB191870)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized SK-OV-3 (Human ovarian cancer cell line) cells labeling PAX8 with ab191870 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nucleus staining on SK-OV-3 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191870 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PAX8 antibody [EPR18715] (AB191870)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized NIH : OVCAR-3 (Human ovary adenocarcinoma cell line) cells labeling PAX8 with ab191870 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nucleus staining on NIH : OVCAR-3 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191870 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR18715] (AB191870)
Immunohistochemical analysis of paraffin-embedded Human endometrium carcinoma tissue labeling PAX8 with ab191870 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nucleus staining on tumor cells of the endometrium carcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR18715] (AB191870)
Immunohistochemical analysis of paraffin-embedded Human thyroid carcinoma tissue labeling PAX8 with ab191870 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nucleus staining on tumor cells of thyroid carcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-Fr
Lab
Immunohistochemistry (Frozen sections) - Anti-PAX8 antibody [EPR18715] (AB191870)
Immunohistochemistry (Frozen sections) analysis of mouse kidney tissue labelling PAX8 with ab191870 at a dilution of 1/500. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG was used as the secondary antibody (1/1000). Nuclear staining is visible in the mouse kidney.
- WB
Supplier Data
Western blot - Anti-PAX8 antibody [EPR18715] (AB191870)
Blocking/Dilution buffer : 5% NFDM/TBST.
PAX8 is expressed in the excretory system and thyroid gland. (PMID : 1723950, 9590297, 1069301)
All lanes:
Western blot - Anti-PAX8 antibody [EPR18715] (ab191870) at 1/1000 dilution
Lane 1:
Human thyroid cancer lysate at 10 µg
Lane 2:
Human fetal liver lysate at 10 µg
Lane 3:
Human fetal heart lysate at 10 µg
Lane 4:
Human fetal kidney lysate at 10 µg
Lane 5:
Human fetal spleen lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 48 kDa
Observed band size: 48 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-PAX8 antibody [EPR18715] (AB191870)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-PAX8 antibody [EPR18715] (ab191870) at 1/1000 dilution
Lane 1:
NIH:OVCAR-3 (Human ovary adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 2:
SK-OV-3 (Human ovarian cancer cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/10000 dilution
Predicted band size: 48 kDa
Observed band size: 48 kDa
false
Exposure time: 3min
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-PAX8 antibody [EPR18715] (AB191870)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 NIH : OVCAR-3 (Human ovary adenocarcinoma epithelial cell) cells and 5 µg of ab191870 [EPR18715]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods."
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-PAX8 antibody [EPR18715] (AB191870)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 NIH : OVCAR-3 (Human ovary adenocarcinoma epithelial cell) cells and 5 µg of ab191870 [EPR18715]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods."
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-PAX8 antibody [EPR18715] (AB191870)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 NIH : OVCAR-3 (Human ovary adenocarcinoma epithelial cell) cells and 5 µg of ab191870 [EPR18715]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods."
Related conjugates and formulations (3)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PAX8 antibody [EPR18715]
-
Anti-PAX8 antibody [EPR18715] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PAX8 antibody [EPR18715]
Reactivity data
Product details
What is this antibody validated in?
Anti-PAX8 antibody [EPR18715] (ab191870) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse samples.
What is the molecular weight of PAX8?
Anti-PAX8 [EPR18715] (ab191870) specifically detects a band for PAX8 (UniProt: Q06710) at a molecular weight of 48kDa.
Trusted by the scientific community
Anti-PAX8 [EPR18715] (ab191870) was first used in a scientific publication in 2015 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR18715] also available for your convenience: ab191870, Alexa Fluor® 488 - ab214955, Alexa Fluor® 647 - ab215953, Alexa Fluor® 555 - ab217733, Carrier free - ab246332
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The PAX8 protein regulates the expression of genes related to organogenesis and cell fate determination. It forms part of transcriptional regulatory complexes partnering with other proteins to modulate gene activity. PAX8 supports embryonic development especially in the thyroid and urogenital tract. Its presence ensures the proper function and formation of these organs highlighting its significance in developmental biology.
Pathways
PAX8 interacts with several key biological processes. It notably participates in the thyroid hormone synthesis pathway where it regulates the expression of thyroglobulin and thyroperoxidase. PAX8 also affects the renal system through its interaction with WT1 a protein involved in kidney development. These pathways illustrate PAX8's role in maintaining endocrine and renal functions by influencing important protein interactions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 44:282 PubMed41057919
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8822 PubMed41044182
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature protocols : PubMed40813913
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 8:1156 PubMed40764744
2025
Applications
Unspecified application
Species
Unspecified reactive species
Glia 72:1604-1628 PubMed38785355
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 42:260 PubMed37803448
2023
Applications
Unspecified application
Species
Unspecified reactive species
Disease models & mechanisms 16: PubMed37655466
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36614229
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 20:558 PubMed36463235
2022
Applications
Unspecified application
Species
Unspecified reactive species
Blood cancer discovery 4:12-33 PubMed36322781
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com